Expenditures related to oncological benefits in Poland 2013-2021
State spending on oncology in Poland in 2021 will amount to 12 billion zloty, an increase of 5.3 percent compared to 2020.
Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Oncology
Cancer facts
5
- Premium Statistic Global death rate - leading causes 2019
- Basic Statistic Cancer deaths worldwide by major type 2020
- Basic Statistic U.S. Americans with a history of cancer living 2004-2022
- Premium Statistic Number of new cancer cases in U.S. from 1999 to 2019
- Premium Statistic Deaths by cancer in the U.S. 1950-2019
Oncology market
6
- Premium Statistic Global oncology spending 2011-2023
- Basic Statistic Spending and growth worldwide in oncology market 2022-2026
- Premium Statistic Oncology medicine spending growth 2014-2018, by region
- Premium Statistic Predicted oncology spending in 2023, by region
- Premium Statistic Emerging cancer diagnostics market size by world region 2015 and 2023
- Premium Statistic Oncology therapeutic market growth U.S. 2016-2021, by segment
Companies
7
- Premium Statistic Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
- Premium Statistic Global top pharmaceutical companies by oncology market share 2017 and 2024
- Basic Statistic Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2022
- Basic Statistic Celgene's top product revenues 2013-2018
- Premium Statistic Bristol-Myers Squibb's top products based on revenue 2016-2021
- Basic Statistic U.S. venture investments in oncology companies 2006-2022
- Basic Statistic U.S. oncology company IPO money raised 2006-2021
Cancer drugs
5
- Premium Statistic Top 5 worldwide oncology products by revenue 2017 and 2024
- Premium Statistic Top 5 worldwide oncology products by market share 2017 and 2024
- Premium Statistic Availability of new cancer drugs by country as of 2018
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Premium Statistic Number of cancer drugs by cost and number of patients U.S. 2017
Research and development
6
- Premium Statistic FDA on breakthrough therapy requests by therapy area 2019
- Basic Statistic FDA on breakthrough therapy requests granted by therapy area 2019
- Premium Statistic Distribution of late phase oncology pipeline 2008 vs. 2018 by type
- Premium Statistic Number of cancer drugs in development in the U.S. 2005-2018
- Premium Statistic Time from R&D start to approval of select cancer drugs 2017
- Premium Statistic Total R&D costs including costs of capital for select cancer drugs 2017
Immuno-oncology
5
- Basic Statistic Worldwide top drug producing mechanisms of action by number of active compounds 2022
- Premium Statistic Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action
- Premium Statistic Global cancer immunotherapy market size 2016 and 2022 forecast
- Premium Statistic Global cancer immunotherapy sales share by type 2021 forecast
- Premium Statistic Leading cancer immunotherapy collaborations worldwide by value 2018
Treatment types
5
- Premium Statistic Distribution of treatment types for female breast cancer by stage 2018
- Basic Statistic Distribution of treatment types for prostate cancer 2010-2012
- Premium Statistic Distribution of treatment types for colon cancer by stage 2018
- Premium Statistic Distribution of treatment types for lung cancer in the U.S. 2018
- Basic Statistic Distribution of treatment types for non-Hodgkin lymphoma 2013
Physicians and patients
8
- Premium Statistic Number of oncologists per one million people by select country 2018
- Basic Statistic Number of active physicians in the U.S. 2022 by specialty area
- Basic Statistic Number of oncology specialty physicians in the U.S. 2016
- Premium Statistic Number of hours U.S. oncologists spend a week seeing patients 2018
- Premium Statistic Number of minutes U.S. oncologists spend with each patient 2018
- Basic Statistic Cancer patients using medication in select countries 2018
- Premium Statistic Cancer sufferers based on lifestyle habits by select country 2019
- Premium Statistic Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017
Further related statistics
16
- Number of patients in oncology wards in hospitals in Poland 2012-2019
- Number of non-Hodgkin lymphoma cancer deaths in U.S. from 1999-2019
- Rate of stomach cancer deaths in U.S. 1999-2019
- Rate of non-Hodgkin lymphoma deaths in U.S. 1999-2019
- Number of deaths due to thyroid cancer in U.S. 1999-2019
- Number of larynx cancer deaths in U.S. from 1999-2019
- Rate of oral cavity and pharynx cancer deaths in U.S. 1999-2019
- Rate of urinary bladder cancer deaths in U.S. 1999-2019
- Share of hospital stays in U.S. from super-utilizers by payer 2012
- Mean hospital costs for U.S. super-utilizers and other patients by payer 2012
- Total hospital costs for U.S. super-utilizers and other patients by payer 2012
- Rate of myeloma deaths in U.S. 1999-2019
- Rate of thyroid cancer deaths in U.S. 1999-2019
- Rate of kidney and renal pelvis cancer death in U.S. 1999-2019
- Number of oral cavity and pharynx cancer deaths in U.S. 1999-2019
- Number of deaths due to urinary bladder cancer in U.S. 1999-2019
Further Content: You might find this interesting as well
Statistics
- Number of patients in oncology wards in hospitals in Poland 2012-2019
- Number of non-Hodgkin lymphoma cancer deaths in U.S. from 1999-2019
- Rate of stomach cancer deaths in U.S. 1999-2019
- Rate of non-Hodgkin lymphoma deaths in U.S. 1999-2019
- Number of deaths due to thyroid cancer in U.S. 1999-2019
- Number of larynx cancer deaths in U.S. from 1999-2019
- Rate of oral cavity and pharynx cancer deaths in U.S. 1999-2019
- Rate of urinary bladder cancer deaths in U.S. 1999-2019
- Share of hospital stays in U.S. from super-utilizers by payer 2012
- Mean hospital costs for U.S. super-utilizers and other patients by payer 2012
- Total hospital costs for U.S. super-utilizers and other patients by payer 2012
- Rate of myeloma deaths in U.S. 1999-2019
- Rate of thyroid cancer deaths in U.S. 1999-2019
- Rate of kidney and renal pelvis cancer death in U.S. 1999-2019
- Number of oral cavity and pharynx cancer deaths in U.S. 1999-2019
- Number of deaths due to urinary bladder cancer in U.S. 1999-2019
Twitter (@MZ_GOV_PL), & Twitter (@PremierRP). (February 4, 2021). Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty) [Graph]. In Statista. Retrieved February 09, 2023, from https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL), und Twitter (@PremierRP). "Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty)." Chart. February 4, 2021. Statista. Accessed February 09, 2023. https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL), Twitter (@PremierRP). (2021). Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty). Statista. Statista Inc.. Accessed: February 09, 2023. https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL), and Twitter (@PremierRP). "Expenses on The Reimbursement of Oncological Medicines and Oncological Benefits in Poland from 2013 to 2021 (in Billion Zloty)." Statista, Statista Inc., 4 Feb 2021, https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/
Twitter (@MZ_GOV_PL) & Twitter (@PremierRP), Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty) Statista, https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/ (last visited February 09, 2023)
Expenses on the reimbursement of oncological medicines and oncological benefits in Poland from 2013 to 2021 (in billion zloty) [Graph], Twitter (@MZ_GOV_PL), & Twitter (@PremierRP), February 4, 2021. [Online]. Available: https://www.statista.com/statistics/1100112/poland-expenditure-related-to-oncological-benefits/